Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0135
Source ID: NCT06598631
Associated Drug: Volenrelaxin
Title: Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Chronic Kidney Disease
Interventions: DRUG: Volenrelaxin|DRUG: Placebo
Outcome Measures: Primary: Percent Change from Baseline of Urine Albumin-Creatinine Ratio (UACR), Baseline, Week 12 | Secondary: Change from Baseline in Estimated Glomerular Filtration Rate (eGFR), Calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation \[2009\], Baseline, Week 12|Change from Baseline in eGFR, Calculated using the CKD-EPI creatinine equation \[2021\], Baseline, Week 12
Sponsor/Collaborators: Sponsor: Eli Lilly and Company
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 8
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2024-10-09
Completion Date: 2024-12-30
Results First Posted:
Last Update Posted: 2025-01-28
Locations: Rancho Research Institute, Downey, California, 90242, United States|Southwest Nephrology Associates, Evergreen Park, Illinois, 60805, United States|Nephrology Associates of Northern Illinois and Indiana (NANI) - Hinsdale, Hinsdale, Illinois, 60521, United States|Nephrology Associates of Northern Illinois and Indiana (NANI) - Huntley, Huntley, Illinois, 60142, United States|Nephrology Associates of Northern Illinois and Indiana (NANI) - Fort Wayne, Fort Wayne, Indiana, 46804, United States|Nephrology Associates of Northern Illinois and Indiana - IKS - Indianapolis South, Indianapolis, Indiana, 46227, United States|Diabetes and Metabolism Associates, APMC, Metairie, Louisiana, 70006, United States|Elite Clinical Research Center, Flint, Michigan, 48532, United States|Eastern Nephrology Associates - Greenville, Greenville, North Carolina, 27834, United States|Eastern Nephrology Associates, Jacksonville, North Carolina, 28546, United States|Eastern Nephrology Associates- Kinston Office, Kinston, North Carolina, 28504, United States|Lucas Research, Inc., Morehead City, North Carolina, 28557, United States|Eastern Nephrology Associates- New Bern Office, New Bern, North Carolina, 28562, United States|Eastern Nephrology Associates - Wilmington, Wilmington, North Carolina, 28401, United States|Endocrine Associates, Houston, Texas, 77004, United States|Permian Research Foundation, Odessa, Texas, 79761, United States|Renal Research - Gosford, Gosford, New South Wales, 2250, Australia|Liverpool Hospital, Liverpool, New South Wales, 2170, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, 6150, Australia|Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, 100029, China|Peking University First Hospital, Beijing, Beijing, 100034, China|Taian City Central Hospital, Taian, Shandong, 271000, China|Yantai Yuhuangding Hospital, Yantai, Shandong, 264099, China|Ningbo 2nd Hospital, Ningbo, Zhejiang, 315000, China|The first affiliated hospital of Ningbo university, Ningbo, Zhejiang, 315010, China|Takai Internal Medicine Clinic, Kamakura-shi, Kanagawa, 247-0056, Japan|Niigata University Medical & Dental Hospital, Niigata, 951-8520, Japan|Okayama University Hospital, Okayama, 700-8558, Japan|CHUAC-Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña [La Coruña], 15006, Spain|Hospital Universitario Virgen de la Victoria, Malaga, Andalucía, 29010, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], 08035, Spain|Hospital Ribera Polusa, Lugo, Lugo [Lugo], 27004, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De, 28222, Spain|Hospital Clinico de Valencia, Valencia, Valenciana, Comunitat, 46010, Spain
URL: https://clinicaltrials.gov/show/NCT06598631

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress